Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Neuropsychological Rehabilitation
|
April 30, 2016
Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness
Hélène Imbeault, Lise Gagnon, Hélène Pigot, et al.
Discovery Medicine
|
February 5, 2013
Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background
Tamas Fulop, Guy Lacombe, Stephen Cunnane, et al.
Discovery Medicine
|
February 5, 2013
Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm
Tamas Fulop, Guy Lacombe, Stephen Cunnane, et al.
Journal of the American Geriatrics Society
|
February 17, 2017
Multicenter Validation of an MMSE-MoCA Conversion Table
David Bergeron, Kelsey Flynn, Louis Verret, et al.
Vaccines
|
April 23, 2022
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Tamas Fulop, Anis Larbi, Graham Pawelec, et al.
Frontiers in Aging Neuroscience
|
August 9, 2018
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?
Tamas Fulop, Jacek M Witkowski, Karine Bourgade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Paolo Vitali, Nesrine Rahmouni, Yansheng Zheng, et al.
Journal of Alzheimer'S Disease : JAD
|
February 4, 2017
A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study
Christian-Alexandre Castellano, Nancy Paquet, Isabelle J Dionne, et al.
Expert Review of Neurotherapeutics
|
August 8, 2023
Viruses - a major cause of amyloid deposition in the brain
Tamas Fulop, Charles Ramassamy, Simon Lévesque, et al.
Journal of Alzheimer'S Disease : JAD
|
March 20, 2025
Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ<sub>1-42</sub>-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease
Mehdi Alami, Echarki Zerif, Abdelouahed Khalil, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Neuropsychological Rehabilitation
|
April 30, 2016
Impact of AP@LZ in the daily life of three persons with Alzheimer's disease: long-term use and further exploration of its effectiveness
Hélène Imbeault, Lise Gagnon, Hélène Pigot, et al.
Discovery Medicine
|
February 5, 2013
Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background
Tamas Fulop, Guy Lacombe, Stephen Cunnane, et al.
Discovery Medicine
|
February 5, 2013
Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm
Tamas Fulop, Guy Lacombe, Stephen Cunnane, et al.
Journal of the American Geriatrics Society
|
February 17, 2017
Multicenter Validation of an MMSE-MoCA Conversion Table
David Bergeron, Kelsey Flynn, Louis Verret, et al.
Vaccines
|
April 23, 2022
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Tamas Fulop, Anis Larbi, Graham Pawelec, et al.
Frontiers in Aging Neuroscience
|
August 9, 2018
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?
Tamas Fulop, Jacek M Witkowski, Karine Bourgade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Paolo Vitali, Nesrine Rahmouni, Yansheng Zheng, et al.
Journal of Alzheimer'S Disease : JAD
|
February 4, 2017
A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study
Christian-Alexandre Castellano, Nancy Paquet, Isabelle J Dionne, et al.
Expert Review of Neurotherapeutics
|
August 8, 2023
Viruses - a major cause of amyloid deposition in the brain
Tamas Fulop, Charles Ramassamy, Simon Lévesque, et al.
Journal of Alzheimer'S Disease : JAD
|
March 20, 2025
Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ<sub>1-42</sub>-induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease
Mehdi Alami, Echarki Zerif, Abdelouahed Khalil, et al.
Page
of 2